Canaan

Canaan Partners invests in entrepreneurs and works alongside them to turn visionary ideas into valuable companies. Since 1987, the firm has catalyzed the growth of disruptive technology startups and healthcare companies revolutionizing the practice of medicine. With $4.2 billion under management and over 180 exits to date, Canaan has funded technology companies such as Lending Club (NYSE LC), SuccessFactors (acquired by SAP), DoubleClick (acquired by Google), Match.com (acquired by IAC), Acme Packet (NASDAQ: APKT), Active Network (NYSE: ACTV), ID Analytics (acquired by LifeLock) and SandForce (acquired by LSI), as well as notable healthcare companies such as Advanced BioHealing (acquired by Shire); Advance PCS (acquired by Caremark), BiPar Sciences (acquired by Sanofi); Calixa Therapeutics (acquired by Cubist); Cerexa Pharmaceuticals (acquired by Forest Labs); Durata Therapeutics (NASDAQ: DRTX) and Elevation Pharmaceuticals (acquired by Sunovion). Current technology investments include KABAM, Zoosk and Blurb in the US; and LiveU and CallmyName in Israel. The Canaan healthcare portfolio includes emerging leaders such as Liquidia Technologies, Theraclone Sciences, and DICOM Grid. Canaan maintains a presence in the global innovation hubs of New York, Silicon Valley and Israel. Visit us at www.canaan.com or www.facebook.com/canaanpartners.